Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KZR Kezar Life Sciences Inc.

Closed Good Friday 04-17 16:00:00 EDT

4.16

+0.10

+2.46%

盘后4.16

+0.000.00%

16:05 EDT

High4.32	Low4.11	Vol6.49K
Open4.14	D1 Closing4.06	Amplitude5.17%
Mkt Cap30.39M	Tradable Cap20.44M	Total Shares7.31M
T/O27.16K	T/O Rate0.13%	Tradable Shares4.91M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"KZR","market":"US","secType":"STK","nameCN":"Kezar Life Sciences Inc.","latestPrice":4.16,"timestamp":1744920000000,"preClose":4.06,"halted":0,"volume":6491,"hourTrading":{"tag":"盘后","latestPrice":4.16,"preClose":4.16,"latestTime":"16:05 EDT","volume":35,"amount":145.6,"timestamp":1744920315275},"delay":0,"floatShares":4913992,"shares":7305800,"eps":-11.486033,"marketStatus":"Closed Good Friday","change":0.1,"latestTime":"04-17 16:00:00 EDT","open":4.142,"high":4.32,"low":4.11,"amount":27162.4816,"amplitude":0.051724,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.486033,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":4.06,"postHourTrading":{"tag":"盘后","latestPrice":4.16,"preClose":4.16,"latestTime":"16:05 EDT","volume":35,"amount":145.6,"timestamp":1744920315275},"volumeRatio":0.2813781523378317,"impliedVol":0.9031,"impliedVolPercentile":0.076},"requestUrl":"/m/hq/s/KZR","defaultTab":"news","newsList":[{"id":"2524112194","title":"Kezar Life Sciences Appoints New Principal Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2524112194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524112194?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 04:29","pubTimestamp":1743539379,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences ( ($KZR) ) has shared an update. On March 27, 2025, Kezar Life Sciences announced the appointment of Pichi (Pattie) Chiang as t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kezar-life-sciences-appoints-new-principal-accounting-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kezar-life-sciences-appoints-new-principal-accounting-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4566","BK4162","PFG","KZR","BK4139","BK4585","BK4588","LU1989772840.SGD","LU1989772923.USD"],"gpt_icon":0},{"id":"2522885823","title":"William Blair Sticks to Their Buy Rating for Kezar Life Sciences (KZR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522885823","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522885823?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 23:25","pubTimestamp":1742916338,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps reiterated a Buy rating on Kezar Life Sciences (KZR – Research Report) today. The company’s shares opened today a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-buy-rating-for-kezar-life-sciences-kzr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-buy-rating-for-kezar-life-sciences-kzr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR"],"gpt_icon":0},{"id":"2522022519","title":"Kezar Life Sciences Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522022519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522022519?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 20:00","pubTimestamp":1742904053,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences Inc reports results for the quarter ended December 31 - Earnings SummaryKezar Life Sciences Inc KZR.OQ reported a quarterly adjusted loss of $2.77 per share for the quarter ended D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL5N3Q80TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR"],"gpt_icon":0},{"id":"2522024228","title":"Kezar Life Sciences Q4 2024 GAAP EPS $(2.77) Beats $(2.88) Estimate, Cash $132M","url":"https://stock-news.laohu8.com/highlight/detail?id=2522024228","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522024228?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 19:55","pubTimestamp":1742903703,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(2.77) per share which beat the analyst consensus estimate of $(2.88) by 3.82 percent. This is a 37.05 percent increase over losses of $(4.40) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44471255/kezar-life-sciences-q4-2024-gaap-eps-2-77-beats-2-88-estimate-cash-132m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR"],"gpt_icon":0},{"id":"2521747128","title":"Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747128","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747128?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 20:00","pubTimestamp":1742817600,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, CALIF., March 24, 2025----Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that it will present topline results from the PORTOLA Phase 2a trial evaluating zetomipzomib for the treatment of patients with autoimmune hepatitis  on Tuesday, March 25, 2025, at 8:00 a.m. ET.The event will highlight topline data from Kezar’s PORTOLA trial, a placebo-controlled, randomized, double-blind Phase 2a clinical trial evaluating the efficacy and safety of zetomipzomib in patients with AIH. Additionally, the event will feature presentations from Craig Lammert, MD, Associate Professor of Medicine at Indiana University School of Medicine and a principal investigator on the PORTOLA trial, and Gideon Hirschfield, PhD, the Lily and Terry Horner Chair in Autoimmune Liver Disease Research, and Director of the Francis Family Liver Clinic at Toronto General Hospit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kezar-life-sciences-present-topline-120000618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALT","BK4196","KZR","BK4139","BK4599","LU1878469433.USD","AIH"],"gpt_icon":0},{"id":"2518895727","title":"Kalamazoo Resources Concludes Funding Arrangement with Lind Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2518895727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518895727?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 05:40","pubTimestamp":1741642837,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Kalamazoo Resources Ltd. ( ($AU:KZR) ). Kalamazoo Resources Limited has concluded its funding arrangement with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-concludes-funding-arrangement-with-lind-partners?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-concludes-funding-arrangement-with-lind-partners?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2518624268","title":"Kezar Life Sciences Inc  expected to post a loss of $2.88 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2518624268","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518624268?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 19:18","pubTimestamp":1741605485,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences Inc  expected to post a loss of $2.88 a share - Earnings Preview Kezar Life Sciences Inc KZR.OQ KZR.O is expected to show no change in quarterly revenue when it reports  results on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL8N3PT0OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR"],"gpt_icon":0},{"id":"2514324264","title":"TD Cowen Keeps Their Buy Rating on Kezar Life Sciences (KZR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514324264?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 21:38","pubTimestamp":1740749882,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Phil Nadeau maintained a Buy rating on Kezar Life Sciences (KZR – Research Report) today. The company’s shares closed yesterday at...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-buy-rating-on-kezar-life-sciences-kzr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-buy-rating-on-kezar-life-sciences-kzr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","TD","COWN"],"gpt_icon":0},{"id":"2514091578","title":"William Blair Sticks to Its Hold Rating for Kezar Life Sciences (KZR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514091578?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 21:17","pubTimestamp":1740489473,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps maintained a Hold rating on Kezar Life Sciences (KZR – Research Report) today. The company’s shares closed yester...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-its-hold-rating-for-kezar-life-sciences-kzr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-its-hold-rating-for-kezar-life-sciences-kzr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR"],"gpt_icon":0},{"id":"2512947791","title":"Kezar Life Sciences to Present at Virtual Kol Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update From the Palizade Trial for Lupus Nephritis on February 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512947791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512947791?lang=en_us&edition=full_marsco","pubTime":"2025-02-19 05:01","pubTimestamp":1739912460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nTUA7YPW0V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2509651297","title":"Kalamazoo Resources Issues Over Two Million Shares Under Placement Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2509651297","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509651297?lang=en_us&edition=full_marsco","pubTime":"2025-02-07 13:39","pubTimestamp":1738906773,"startTime":"0","endTime":"0","summary":"An announcement from Kalamazoo Resources Ltd. ( ($AU:KZR) ) is now available. Kalamazoo Resources Limited has issued 2,205,883 shares as part of a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-over-two-million-shares-under-placement-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-over-two-million-shares-under-placement-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2509765162","title":"Kalamazoo Resources Ltd. Quotes New Securities on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2509765162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509765162?lang=en_us&edition=full_marsco","pubTime":"2025-02-07 13:34","pubTimestamp":1738906478,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. ( ($AU:KZR) ) has provided an update. Kalamazoo Resources Ltd. has announced the quotation of 2,205,883 new fully paid ord...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-ltd-quotes-new-securities-on-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-ltd-quotes-new-securities-on-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2509263574","title":"BRIEF-Kezar Life Sciences Files For Mixed Shelf Of Upto $400 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2509263574","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509263574?lang=en_us&edition=full_marsco","pubTime":"2025-02-06 07:22","pubTimestamp":1738797749,"startTime":"0","endTime":"0","summary":"BRIEF-Kezar Life Sciences Files For Mixed Shelf Of Upto $400 MillionFeb 5 (Reuters) - Kezar Life Sciences Inc KZR.O:KEZAR LIFE SCIENCES, INC. FILES FOR MIXED SHELF OF UPTO $400 MILLIONSource text: [ID:n0001193125-25-020894]Further company coverage: KZR.O ((reuters.briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW23G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2509268801","title":"Kezar Life Sciences Files $400 Million Mixed Securities Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2509268801","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509268801?lang=en_us&edition=full_marsco","pubTime":"2025-02-06 06:55","pubTimestamp":1738796110,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences  filed a shelf registration statement with the US Securities and Exchange Commission Wednesday covering the potential sale of up to $400 million of securities from time to time in one or more offerings.The statement covers common and preferred stock, debt securities, and warrants.The company said it plans to use any net proceeds generated from the securities sale for working capital and general corporate purposes.Kezar shares were down 2.7% in after-hours activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KZR","KZR.AU","BK4139","BK7095"],"gpt_icon":0},{"id":"2509925729","title":"Kezar Life Sciences files $400M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2509925729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509925729?lang=en_us&edition=full_marsco","pubTime":"2025-02-06 06:25","pubTimestamp":1738794307,"startTime":"0","endTime":"0","summary":"17:20 EST Kezar Life Sciences (KZR) files $400M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kezar-life-sciences-files-400m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kezar-life-sciences-files-400m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2509257921","title":"Kezar Life Sciences, Inc. Files for Mixed Shelf of Upto $400 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2509257921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509257921?lang=en_us&edition=full_marsco","pubTime":"2025-02-06 06:21","pubTimestamp":1738794087,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW23G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2505000806","title":"Kalamazoo Resources Ltd Advances Gold Projects with Strategic Agreements and Financial Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2505000806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505000806?lang=en_us&edition=full_marsco","pubTime":"2025-01-24 13:21","pubTimestamp":1737696078,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. ( ($AU:KZR) ) has issued an update. Kalamazoo Resources Ltd reported significant progress on its gold projects in Western ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-ltd-advances-gold-projects-with-strategic-agreements-and-financial-initiatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-ltd-advances-gold-projects-with-strategic-agreements-and-financial-initiatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2505007630","title":"Kalamazoo Resources Reports Quarterly Financials with Positive Cash Flow from Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2505007630","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505007630?lang=en_us&edition=full_marsco","pubTime":"2025-01-24 13:08","pubTimestamp":1737695318,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Kalamazoo Resources Ltd. ( ($AU:KZR) ). Kalamazoo Resources Ltd. reported its quarterly cash flow, showcasing a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-reports-quarterly-financials-with-positive-cash-flow-from-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-reports-quarterly-financials-with-positive-cash-flow-from-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2503347619","title":"Kalamazoo Resources Issues New Shares to Strengthen Market Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2503347619","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503347619?lang=en_us&edition=full_marsco","pubTime":"2025-01-13 13:37","pubTimestamp":1736746677,"startTime":"0","endTime":"0","summary":"An update from Kalamazoo Resources Ltd. ( ($AU:KZR) ) is now available. Kalamazoo Resources Limited has announced the issuance of 2,272,728 fully p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-new-shares-to-strengthen-market-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-new-shares-to-strengthen-market-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2492747581","title":"Kezar Life Sciences Is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2492747581","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492747581?lang=en_us&edition=full_marsco","pubTime":"2024-12-19 23:02","pubTimestamp":1734620520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KZR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 19, 2024 10:02 ET (15:02 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","LU0162691827.USD","BK4588","LU0048573561.USD","LU0289960550.SGD","LU0256863811.USD","IE00B19Z3B42.SGD","LU0128525689.USD","LU0742534661.SGD","BK4501","BK4504","LU0052756011.USD","LU2236285917.USD","LU0683600562.USD","LU0070302665.USD","LU1201861249.SGD","LU0130102774.USD","KZR","LU1267930573.SGD","LU2361044949.HKD","LU2361044865.SGD","LU0208291251.USD","BK4585","LU0251131958.USD","LU0128525929.USD","BK4207","LU0477156953.USD","LU0971096721.USD","LU1035773651.USD","LU0149725797.USD","LU1069347547.HKD","LU0787776722.HKD","LU0980610538.SGD","LU0130517989.USD","IE0002270589.USD","LU1814569148.SGD","LU1280957306.USD","LU0175139822.USD","LU0251142724.SGD","LU2461242641.AUD","IE00B7SZLL34.SGD","LU0029864427.USD","LU0106831901.USD","LU2361045086.USD","LU0640476718.USD","BK4559","LU0648001328.SGD","BK4139","LU0320765489.SGD","LU1074936037.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kezarlifesciences.com","stockEarnings":[{"period":"1week","weight":0.0532},{"period":"1month","weight":-0.2803},{"period":"3month","weight":-0.3279},{"period":"6month","weight":-0.495},{"period":"1year","weight":-0.4906},{"period":"ytd","weight":-0.381}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.09183},{"month":2,"riseRate":0.714286,"avgChangeRate":0.077321},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.102159},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.088861},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.18188},{"month":6,"riseRate":0.333333,"avgChangeRate":0.038813},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.058216},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.003228},{"month":9,"riseRate":0.428571,"avgChangeRate":0.037638},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.061141},{"month":11,"riseRate":0.857143,"avgChangeRate":0.174913},{"month":12,"riseRate":0.428571,"avgChangeRate":0.037615}],"exchange":"NASDAQ","name":"Kezar Life Sciences Inc.","nameEN":"Kezar Life Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kezar Life Sciences Inc.(KZR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kezar Life Sciences Inc.,KZR,Kezar Life Sciences Inc.股票,Kezar Life Sciences Inc.股票老虎,Kezar Life Sciences Inc.股票老虎国际,Kezar Life Sciences Inc.行情,Kezar Life Sciences Inc.股票行情,Kezar Life Sciences Inc.股价,Kezar Life Sciences Inc.股市,Kezar Life Sciences Inc.股票价格,Kezar Life Sciences Inc.股票交易,Kezar Life Sciences Inc.股票购买,Kezar Life Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kezar Life Sciences Inc.(KZR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction